TTR mouse Monoclonal Antibody(5G9)

This gene encodes transthyretin, one of the three prealbumins including alpha-1-antitrypsin, transthyretin and orosomucoid. Transthyretin is a carrier protein; it transports thyroid hormones in the plasma and cerebrospinal fluid, and also transports retinol (vitamin A) in the plasma. The protein consists of a tetramer of identical subunits. More than 80 different mutations in this gene have been reported; most mutations are related to amyloid deposition, affecting predominantly peripheral nerve and/or the heart, and a small portion of the gene mutations is non-amyloidogenic. The diseases caused by mutations include amyloidotic polyneuropathy, euthyroid hyperthyroxinaemia, amyloidotic vitreous opacities, cardiomyopathy, oculoleptomeningeal amyloidosis, meningocerebrovascular amyloidosis, carpal tunnel syndrome, etc.

Introducing the TTR Mouse Monoclonal Antibody (5G9), a cutting-edge product designed to revolutionize the field of biomedical research. This highly advanced antibody is meticulously engineered to specifically target and bind to Transthyretin (TTR), a protein of utmost significance in various physiological processes.

The TTR Mouse Monoclonal Antibody (5G9) boasts exceptional specificity and sensitivity, enabling researchers to accurately detect and quantify TTR levels in biological samples. Its unrivaled affinity for TTR ensures precise and reliable results, facilitating a deeper understanding of TTR's role in disease progression and therapeutic interventions.

Crafted with utmost precision and utilizing state-of-the-art technology, this antibody guarantees reproducibility and consistency, making it an indispensable tool for researchers seeking to unravel the intricate mechanisms underlying TTR-related disorders. Its robust performance and versatility render it suitable for a wide range of applications, including Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISA).

Furthermore, the TTR Mouse Monoclonal Antibody (5G9) exhibits exceptional stability, ensuring prolonged shelf life and optimal performance even under challenging experimental conditions. Its user-friendly nature simplifies experimental procedures, allowing researchers to focus on their scientific endeavors without unnecessary complications.

In summary, the TTR Mouse Monoclonal Antibody (5G9) represents a breakthrough in the field of biomedical research, offering unparalleled specificity, sensitivity, and reliability. With its remarkable performance and versatility, this antibody is poised to revolutionize the study of TTR-related disorders, paving the way for novel therapeutic strategies and improved patient outcomes.